Alzheimer's disease: a review of the disease, its epidemiology and economic impact (Q33354841)

26 July 2017

0 references

Alzheimer's disease: a review of the disease, its epidemiology and economic impact (English)

1 reference

26 July 2017

0 references

Alloul K

1

1 reference

26 July 2017

Sauriol L

2

1 reference

26 July 2017

Kennedy W

3

1 reference

26 July 2017

Laurier C

4

1 reference

26 July 2017

Tessier G

5

1 reference

26 July 2017

Novosel S

6

1 reference

26 July 2017

Contandriopoulos A

7

1 reference

26 July 2017

language of work or name

1 reference

1 November 1998

1 reference

Archives of Gerontology and Geriatrics

26 July 2017

published in

1 reference

26 July 2017

volume

27

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

189-221

1 reference

A population-based study on the incidence of dementia disorders between 85 and 88 years of age.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Survival in Alzheimer's disease and vascular dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Is the prevalence of dementia changing?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Lack of association between Alzheimer's disease and education, occupation, marital status, or living arrangement

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Predictors of decline in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The EURODEM collaborative re-analysis of case-control studies of Alzheimer's disease: implications for public health

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Epidemiology of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Head trauma with loss of consciousness as a risk factor for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The American and Canadian consensus conferences on dementia: is there consensus?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Presenile dementia. Clinical aspects and evaluation of cerebrospinal fluid dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Range of mental illness among the elderly in the community. Prevalence in Liverpool using the GMS-AGECAT package.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Sources of variability in prevalence rates of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Factors affecting the outcomes of hospitalized dementia patients: from home to hospital to discharge

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The US economic and social costs of Alzheimer's disease revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Cognitive function and the costs of Alzheimer disease. An exploratory study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Estimated prevalence of Alzheimer's disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Dementing disorders in north Italy: prevalence study in Vescovato, Cremona Province.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

1 reference

7 January 2021

Dementia: case ascertainment in a community survey

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Dementia, aluminium, and fluoride

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Reliability of clinical criteria for the diagnosis of dementia. A longitudinal multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Risk factors for late-onset Alzheimer's disease: a population-based, case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Canadian projections of cases suffering from Alzheimer's disease and senile dementia of Alzheimer type over the period 1986-2031.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Evaluation of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The association between aluminum-containing products and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

A case-control study of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The association between head trauma and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Occupational risk factors for Alzheimer disease: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Cerebral blood flow in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Senile dementia of the Alzheimer type in the Lundby Study. I. A prospective, epidemiological study of incidence and risk during the 15 years 1957-1972.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Incidence of Dementia in the Lundby Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The family caregiver's role in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The economic costs of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience, part XVII.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Is parental age related to the risk of Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Evaluation of the costs of caring for the senile demented elderly: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Alzheimer's disease: preliminary study of spatial distribution at birth place

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The prevalence of dementia: a quantitative integration of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Development of dementing illnesses in an 80-year-old volunteer cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Clinical risk factors for Alzheimer's disease: a population-based case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Solvent exposure as a risk factor for Alzheimer's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Smoking and Alzheimer's disease: a review of the epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Risk of dementia among persons with diabetes mellitus: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Smoking and oestrogen-replacement therapy as protective factors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Prevalence of Alzheimer's disease and other dementing disorders in Pamplona, Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Familial Alzheimer's disease and vitamin B12 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Community screening for dementia: the Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Survival and cause of death in Alzheimer's disease and multi-infarct dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Incidence of severe dementia in an urban sample followed from 70 to 79 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Risk factors for admission to a nursing home. A study of elderly people receiving home nursing.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Incontinence and troublesome behaviors predict institutionalization in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Prevalence of Alzheimer's disease in a retirement community

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Prevalence of dementia in an elderly rural population: effects of age, sex, and education

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Head injury as a risk factor in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The economic burden of Alzheimer's disease care

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Maternal age and Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The prevalence of dementia in the elderly: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Severe dementia. Prevalence and clinical features in a biracial US population

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Alzheimer's disease after remote head injury: an incidence study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Patterns and predictors of institutionalization in community-based dementia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Occupational risk factors and Alzheimer's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Electromagnetic field exposure may cause increased production of amyloid beta and eventually lead to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Occupations with exposure to electromagnetic fields: a possible risk factor for alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Elevated risk of Alzheimer's disease among workers with likely electromagnetic field exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Application of a growth curve approach to modeling the progression of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Predicting time to nursing home care and death in individuals with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

The costs of family contributions to the care of persons with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Prevalence of severe dementia in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Survival of patients with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Relation between nicotine intake and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Risk Factors for Alzheimer's Disease: The EURODEM Collaborative Re-Analysis of Case-Control Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Head trauma and the risk of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Survival of outpatients with Alzheimer-type dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Expenditures in caring for patients with dementia who live at home.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Caregiving and Alzheimer's-type disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Predictive validity of factors influencing the institutionalization of elderly people with psycho-geriatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2898%2900116-2

7 January 2021

10.1016/S0167-4943(98)00116-2

Identifiers

DOI

1 reference

26 July 2017

1 reference